Jane Street’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-26,572
Closed -$903 9700
2023
Q2
$903 Sell
26,572
-1,123
-4% -$49 ﹤0.01% 8555
2023
Q1
$1.93K Sell
27,695
-1,186
-4% -$100 ﹤0.01% 8859
2022
Q4
$725 Sell
28,881
-3,074
-10% -$246 ﹤0.01% 8977
2022
Q3
$7K Buy
31,955
+6,247
+24% +$1.54K ﹤0.01% 9409
2022
Q2
$3K Sell
25,708
-563
-2% -$93 ﹤0.01% 9461
2022
Q1
$11K Sell
26,271
-36
-0.1% -$12 ﹤0.01% 10061
2021
Q4
$11K Sell
26,307
-135
-0.5% -$93 ﹤0.01% 9901
2021
Q3
$17K Buy
26,442
+584
+2% +$561 ﹤0.01% 9765
2021
Q2
$39K Buy
25,858
+704
+3% +$1.15K ﹤0.01% 9552
2021
Q1
$43K Buy
+25,154
New +$51K ﹤0.01% 8868

Other funds holding APGNW

Jane Street's APGNW Position: Q3 2023 in Review

Jane Street sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 26,572 shares — an estimated $903 sold.

Jane Street first reported a position in APGNW in Q1 2021 and held it in 10 quarters. The position peaked at $43K in Q1 2021. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

  • Jane Street reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 26,572 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $903.
  • Jane Street first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q1 2021 and held it in 10 quarters.
  • Jane Street's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $43K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.